1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
79
38
1d
2 29
1d
25
38
James F Morley, M.D., Ph.D.
74Associate Professor of Neurology at the Veteran's Administration Medical Center
28
68
3
60
Staff Neurologist, Philadelphia VA Medical Center
95
Associate Director , University of Pennsylvania/PADRECC Movement Disorders Fellowship Program.
99
Director, Parkinson's Disease Research, Education and Clinical Center. Crescenz VA Medical Center
11
Department: Neurology
4
1
b
1d
46
Contact information
69
4
3
3
3
2
4
b
1f
69
Parkinson's Disease Research, Education and Clinical Center
1c 3900 Woodland Ave.
30 Mail Stop 127
Philadelphia, PA 19104
26
1c 3900 Woodland Ave.
30 Mail Stop 127
Philadelphia, PA 19104
2e
Office: 215-823-5934
30
97
30
Email:
james.morley@uphs.upenn.edu
12
james.morley@uphs.upenn.edu
13
Education:
21 9 B.S. c
43 Wharton School, University of Pennsylvania, 1996.
21 a Ph.D. c
30 Northwestern University, 2003.
21 9 M.D. c
4d Feinberg School of Medicine, Northwestern University, 2005.
c
3
3
21
21 9 B.S. c
43 Wharton School, University of Pennsylvania, 1996.
21 a Ph.D. c
30 Northwestern University, 2003.
21 9 M.D. c
4d Feinberg School of Medicine, Northwestern University, 2005.
c
1f
Post-Graduate Training
24 55 Intern in Internal Medicine, University of Pennsylvania, 2005-2006.
24 4f Resident in Neurology, University of Pennsylvania, 2006-2009.
24 56 Fellow in Movement Disorders, University of Pennsylvania, 2009-2011.
c
3
25
24 55 Intern in Internal Medicine, University of Pennsylvania, 2005-2006.
24 4f Resident in Neurology, University of Pennsylvania, 2006-2009.
24 56 Fellow in Movement Disorders, University of Pennsylvania, 2009-2011.
c
17
Certifications
28 43 American Board of Psychiatry and Neurology, 2009.
c
3
8d
Permanent link28 43 American Board of Psychiatry and Neurology, 2009.
c
2 29
21
1e
1d
24
2b
29
27
23
179 Kannartkat, G, Zack, R, Skrinak, R, Morley, J,Davila-Rivera, R, Arezoumandan, S, Dorfman, K, Luk, K, Weintraub, D, Tropea, T, Lee, E, Lee, V, Irwin, D, Akhtar, R, Chen-Plotkin, A : Blood α-synuclein separates Parkinson’s disease from dementia with Lewy bodies. Annals of Neurology 98(4): 682, 2025.
175 Vaughan C.P., Morley J.F., Lehosit J., McGwin G., Muirhead L., Khakharia A., Johnson TM, Evatt ML, Sergent T, Burgio KL, Markland A.D.: Comparative effectiveness non-inferiority trial of behavioral or drug therapy for overactive bladder symptoms in Parkinson disease. JAMA Neurology 82(9): 925, 2025.
13c Morley, J.F., Subramanian, I., Farahnik, J., Grout, L., Salcido, C., Kurtzer, J., Mischley, L.K.: Physical activity, patient-reported outcomes, and quality of life in Parkinson’s disease. J Geriatric Psychiatry and Neurology 39(1): 14, 2025.
fa Vaswani, PA, Morley, JF, Jennings, D, Siderowf, A, Marek, K.: Predictive value of abbreviated olfactory tests in prodromal Parkinson disease. nPJ Parkinson's Disease 9(3), 2023.
175 Waddell, KJ, Patel, MS, Wilkinson, JR, Burke, RE, Bravata, DM, Koganti, S Wood, S, Morley, JF: Deploying Digital Health Technologies for Remote Physical Activity Monitoring of Rural Populations With Chronic Neurologic Disease. Archives of Rehabilitation Research and Clinical Translation 5(1), 2023.
140 Vaswani, P.A., Morley, J.F., Jennings, D., Siderowf, A.D. and Marek, K. for the PARS Investigators: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study. Parkinsonism and Related Disorders 104: 15-20, 2022.
e0 Mantri, S., Fullard, M.E., Duda, J.E., Morley, J.F.: Physical Activity in Early Parkinson Disease. Journal of Parkinson's Disease 8 (1): 107-111, 2018.
1af Morley, J.F., Cohen, A., Silveira-Moriyama, L., Lees, A.J., Williams, D.R., Katzenschlager, R., Hawkes, C., Adelman, J.P., Weintraub, D., Doty, R.L., Duda, J.E. : Optimizing olfactory testing for the diagnosis of Parkinson’s disease: item analysis of the University of Pennsylvania Smell Identification Test. npj Parkinson's Disease 15(4): 2, January 2018.
f8 Fullard, M.E., Tran, B., Xie, S.X., Scordia, C., Linder, C., Purri, Weintraub D., Duda, J.E., Chahine, L., Morley, J.F.: Olfactory impairment predicts cognitive decline in early Parkinson's disease 4a Parkinsonism & Related Disorders 25: 45-51, 2016.
2c
7
1d
1f
Selected Publications
119 Waddell, K.J., Smith, M., Wood S., Patel, M., Greysen, S.R., Morley J.F.: Remote, Automated, Gamification Increases Community-Based Physical Activity in Parkinson’s Disease JAMA Neurology 83(1): 88, 2026.179 Kannartkat, G, Zack, R, Skrinak, R, Morley, J,Davila-Rivera, R, Arezoumandan, S, Dorfman, K, Luk, K, Weintraub, D, Tropea, T, Lee, E, Lee, V, Irwin, D, Akhtar, R, Chen-Plotkin, A : Blood α-synuclein separates Parkinson’s disease from dementia with Lewy bodies. Annals of Neurology 98(4): 682, 2025.
175 Vaughan C.P., Morley J.F., Lehosit J., McGwin G., Muirhead L., Khakharia A., Johnson TM, Evatt ML, Sergent T, Burgio KL, Markland A.D.: Comparative effectiveness non-inferiority trial of behavioral or drug therapy for overactive bladder symptoms in Parkinson disease. JAMA Neurology 82(9): 925, 2025.
13c Morley, J.F., Subramanian, I., Farahnik, J., Grout, L., Salcido, C., Kurtzer, J., Mischley, L.K.: Physical activity, patient-reported outcomes, and quality of life in Parkinson’s disease. J Geriatric Psychiatry and Neurology 39(1): 14, 2025.
fa Vaswani, PA, Morley, JF, Jennings, D, Siderowf, A, Marek, K.: Predictive value of abbreviated olfactory tests in prodromal Parkinson disease. nPJ Parkinson's Disease 9(3), 2023.
175 Waddell, KJ, Patel, MS, Wilkinson, JR, Burke, RE, Bravata, DM, Koganti, S Wood, S, Morley, JF: Deploying Digital Health Technologies for Remote Physical Activity Monitoring of Rural Populations With Chronic Neurologic Disease. Archives of Rehabilitation Research and Clinical Translation 5(1), 2023.
140 Vaswani, P.A., Morley, J.F., Jennings, D., Siderowf, A.D. and Marek, K. for the PARS Investigators: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study. Parkinsonism and Related Disorders 104: 15-20, 2022.
e0 Mantri, S., Fullard, M.E., Duda, J.E., Morley, J.F.: Physical Activity in Early Parkinson Disease. Journal of Parkinson's Disease 8 (1): 107-111, 2018.
1af Morley, J.F., Cohen, A., Silveira-Moriyama, L., Lees, A.J., Williams, D.R., Katzenschlager, R., Hawkes, C., Adelman, J.P., Weintraub, D., Doty, R.L., Duda, J.E. : Optimizing olfactory testing for the diagnosis of Parkinson’s disease: item analysis of the University of Pennsylvania Smell Identification Test. npj Parkinson's Disease 15(4): 2, January 2018.
f8 Fullard, M.E., Tran, B., Xie, S.X., Scordia, C., Linder, C., Purri, Weintraub D., Duda, J.E., Chahine, L., Morley, J.F.: Olfactory impairment predicts cognitive decline in early Parkinson's disease 4a Parkinsonism & Related Disorders 25: 45-51, 2016.
2c